Literature DB >> 18342764

Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications.

Wendy DeMartini1, Constance Lehman, Savannah Partridge.   

Abstract

RATIONALE AND
OBJECTIVES: Breast MRI is an important new tool in the imaging armamentarium for the detection and characterization of breast carcinoma. Understanding the evidence-supported benefits and potential harms of breast MRI is important to ensure the appropriate utilization of this medical resource.
MATERIALS AND METHODS: This article reviews the clinical settings in which MRI for breast cancer assessment has been shown to be advantageous. The evidence regarding the diagnostic accuracy of MRI and the impact of this imaging tool on clinical outcomes are described. Novel breast MRI techniques which may lead to future improvements in performance are discussed.
RESULTS: Breast MRI has been shown in multiple studies to be advantageous for screening patients at high risk, evaluating patients with a new breast cancer diagnosis, monitoring treatment response in patients undergoing neoadjuvant chemotherapy and evaluating patients with metastatic axillary adenocarcinoma and unknown primary site. Among the limitations of MRI are its high cost and modest specificity resulting in false positive examinations.
CONCLUSIONS: When used in evidence-supported clinical settings, the high sensitivity of MRI results in earlier cancer detection or greater accuracy of detection compared to existing tests for breast carcinoma. Further scientific endeavors are crucial to optimize the future performance and application of breast MRI.

Entities:  

Mesh:

Year:  2008        PMID: 18342764     DOI: 10.1016/j.acra.2007.11.006

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  30 in total

Review 1.  Geographic and temporal trends in the management of occult primary breast cancer: a systematic review and meta-analysis.

Authors:  Oluwadamilola M Fayanju; Carolyn R T Stoll; Susan Fowler; Graham A Colditz; Donna B Jeffe; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2013-08-22       Impact factor: 5.344

2.  MRI-based breast volumetry-evaluation of three different software solutions.

Authors:  Christian Herold; A Reichelt; L H Stieglitz; S Dettmer; K Knobloch; J Lotz; P M Vogt
Journal:  J Digit Imaging       Date:  2010-10       Impact factor: 4.056

3.  Molecular imaging of the translocator protein (TSPO) in a pre-clinical model of breast cancer.

Authors:  Shelby K Wyatt; H Charles Manning; Mingfeng Bai; Stephanie N Bailey; Pascal Gallant; Guobin Ma; Laura McIntosh; Darryl J Bornhop
Journal:  Mol Imaging Biol       Date:  2009-12-01       Impact factor: 3.488

4.  Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.

Authors:  Safia Cheeney; Habib Rahbar; Brian N Dontchos; Sara H Javid; Mara H Rendi; Savannah C Partridge
Journal:  J Magn Reson Imaging       Date:  2017-02-09       Impact factor: 4.813

5.  Repeatability of quantitative MRI measurements in normal breast tissue.

Authors:  Sheye O Aliu; Ella F Jones; Ania Azziz; John Kornak; Lisa J Wilmes; David C Newitt; Sachiko A Suzuki; Catherine Klifa; Jessica Gibbs; Evelyn C Proctor; Bonnie N Joe; Nola M Hylton
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

6.  Computerized three-class classification of MRI-based prognostic markers for breast cancer.

Authors:  Neha Bhooshan; Maryellen Giger; Darrin Edwards; Yading Yuan; Sanaz Jansen; Hui Li; Li Lan; Husain Sattar; Gillian Newstead
Journal:  Phys Med Biol       Date:  2011-08-22       Impact factor: 3.609

7.  Computerized assessment of breast lesion malignancy using DCE-MRI robustness study on two independent clinical datasets from two manufacturers.

Authors:  Weijie Chen; Maryellen L Giger; Gillian M Newstead; Ulrich Bick; Sanaz A Jansen; Hui Li; Li Lan
Journal:  Acad Radiol       Date:  2010-07       Impact factor: 3.173

8.  High-resolution diffusion-weighted imaging for the separation of benign from malignant BI-RADS 4/5 lesions found on breast MRI at 3T.

Authors:  Dorota J Wisner; Nathan Rogers; Vibhas S Deshpande; David N Newitt; Gerhard A Laub; David A Porter; John Kornak; Bonnie N Joe; Nola M Hylton
Journal:  J Magn Reson Imaging       Date:  2013-11-08       Impact factor: 4.813

9.  Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization.

Authors:  Quing Zhu; Susan Tannenbaum; Poornima Hegde; Mark Kane; Chen Xu; Scott H Kurtzman
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

10.  Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.

Authors:  Savannah C Partridge; Karen M Stone; Roberta M Strigel; Wendy B DeMartini; Sue Peacock; Constance D Lehman
Journal:  Acad Radiol       Date:  2014-07-04       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.